An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study

Table 2 Association between platelet inhibitor therapy and history of cancer

*Population*	Multivariate (Adjusted) Analyses*
	N	OR	*(95% CI)*	P
All subjects	994	0.66	(0.44, 0.99)	.045
Women	540	0.63	(0.36,1.08)	.09
Men	454	0.71	(0.38,1.32)	.29
Age < 65 years	477	0.93	(0.46, 1.90)	.85
Age 65 years or more	530	0.61	(0.37, 0.99)	.047
Excluding users of non-aspirin inhibitors	925	0.67	(0.44, 1.03)	.07
Excluding users of aspirin	525	0.64	(0.22, 1.80)	.39

*Adjusted for age, sex, body mass index, presence of ≥ 2 co-morbidities, and number of medications. Body mass index was not available for 13 subjects who were excluded from the multivariate analyses.

ISSN: 1471-2407